210 related articles for article (PubMed ID: 30311250)
1. Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?
Shah RR
J Clin Pharm Ther; 2019 Feb; 44(1):129-133. PubMed ID: 30311250
[TBL] [Abstract][Full Text] [Related]
2. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
Hedenmalm K; Spigset O
Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
[TBL] [Abstract][Full Text] [Related]
3. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
Lampl C; Likar R
Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
[TBL] [Abstract][Full Text] [Related]
4. [Agranulocytosis from metamizole: a potential problem for the British population].
Mérida Rodrigo L; Faus Felipe V; Poveda Gómez F; García Alegría J
Rev Clin Esp; 2009 Apr; 209(4):176-9. PubMed ID: 19457324
[TBL] [Abstract][Full Text] [Related]
5. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.
Stammschulte T; Ludwig WD; Mühlbauer B; Bronder E; Gundert-Remy U
Eur J Clin Pharmacol; 2015 Sep; 71(9):1129-38. PubMed ID: 26169297
[TBL] [Abstract][Full Text] [Related]
6. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
[TBL] [Abstract][Full Text] [Related]
7. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
Hoffmann F; Bantel C; Jobski K
Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
[TBL] [Abstract][Full Text] [Related]
8. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
[TBL] [Abstract][Full Text] [Related]
9. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
Klose S; Pflock R; König IR; Linder R; Schwaninger M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
[TBL] [Abstract][Full Text] [Related]
10. [Case Report - Metamizole-Induced Agranulocytosis].
Gonnert FA; Meißner W
Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May; 53(5):388-394. PubMed ID: 29772595
[TBL] [Abstract][Full Text] [Related]
11. Chronic use of metamizole: not so safe after all?
Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
[TBL] [Abstract][Full Text] [Related]
12. [Severe thrombocytopenia and agranulocytosis associated with metamizole].
Fernández García PL; Ibáñez Camacho MF; López Pérez E
Med Clin (Barc); 2016 Oct; 147(8):e43-e44. PubMed ID: 27450174
[No Abstract] [Full Text] [Related]
13. Dipyrone (metamizole) use in the United States: a lethal tango?
Moorman J
South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522
[No Abstract] [Full Text] [Related]
14. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
[TBL] [Abstract][Full Text] [Related]
15. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
Celeketić D; Trpković A; Cvetković Z
Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
[TBL] [Abstract][Full Text] [Related]
16. Agranulocytosis and near fatal sepsis due to 'Mexican aspirin' (dipyrone).
Dorr VJ; Cook J
South Med J; 1996 Jun; 89(6):612-4. PubMed ID: 8638202
[TBL] [Abstract][Full Text] [Related]
17. The incidence of metamizole sodium-induced agranulocytosis in Poland.
Maj S; Lis Y
J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518
[TBL] [Abstract][Full Text] [Related]
18. [Dual agranulocytosis episode likely resulting from metamizole use].
Hemmersbach-Miller M; Conde Martel A; Acosta Artiles M; Suárez Ortega S
Farm Hosp; 2005 Mar; 29(2):148-50. PubMed ID: 16045431
[No Abstract] [Full Text] [Related]
19. Dipyrone and agranulocytosis: what is the risk?
Edwards JE; McQuay HJ
Lancet; 2002 Nov; 360(9344):1438. PubMed ID: 12433507
[No Abstract] [Full Text] [Related]
20. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
